Market News Today — AI-Curated Stock & Crypto Headlines

Filters active
Clear all

7 models read the news here in the last 30 days

Rule-Based Analysis Mistral Small Latest Llama 3.3 70B Versatile (Groq) GPT-OSS 120B (Groq) Qwen3.8 27B (Groq) Gemini 2.5 Flash Gemini Flash Latest
⚡ Real-time 📊 Sentiment Analysis

🧭 Daily Market Digest (Sep 3, 2026) 🤖 AI-Powered

Today’s financial news highlights AI infrastructure growth, mixed industrial sector performance, and geopolitical tensions, with Broadcom’s AI chip revenue surge …

Trending Evidence Watch Active

High-confidence AI observations with source context and evaluated outcome tracking

⚡ Strong Context Economy 95% Mistral Small Latest
95%

US Stock Market Today: S&P 500 Futures Slip As Rising Yields Pressure Equities

The decline in S&P 500 futures may pressure US equities broadly, particularly large-cap stocks sensitive to interest rate …
Bearish
21h ago
Why Now: Exceptional AI confidence + strong market context
📊 Moderate Context Global Markets & Finance 65% Mistral Small Latest
65%

US’s Wright on Venezuela Oil Production, SPR, Strait of Hormuz

The deals with Chevron, ENI, and GE Vernova may signal increased Venezuelan oil production and exports, which could …
Neutral
15h ago
Why Now: Recent high-quality analysis with market relevance
📊 Moderate Context Economy 60% Mistral Small Latest
60%

Update: Wall Street Snaps 3-Day Losing Streak as Yields Edge Down

The rebound in US equities suggests improved investor sentiment, which may positively affect broad equity indices and sectors …
Bullish
8h ago
Why Now: Recent high-quality analysis with market relevance

Search Results for "REVENUE" (1217 articles)

Financial Times
The new rivalry on Wall Street

The article highlights intensifying competition between traditional banks and proprietary trading firms (prop firms) on Wall Street, indicating a structural shift in financial intermediation and market-making dynamics.

Direction Neutral Impact Moderate No call logged Details
Bloomberg
Lilly to Buy Merida for $2.88B in Autoimmune Push

Eli Lilly announced a $2.88 billion cash acquisition of Merida Biosciences to expand into autoimmune and allergic diseases, signaling a strategic shift beyond its core weight-loss and diabetes markets.

$LLY $AMGN $REGN
Direction Bullish Impact High Awaiting evaluation Details

No articles match your filters.

Get Market Intelligence Daily

AI-curated news and analysis — free, straight to your inbox.

🤖

Market Insight

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
Analyzing...
AI Model Multi-Provider AI